{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:35:54Z","timestamp":1794375354802,"version":"4.9.0"},"reference-count":52,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,11,21]],"date-time":"2008-11-21T00:00:00Z","timestamp":1227225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Milbank Quarterly"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:p>\n                    <jats:bold>Context:<\/jats:bold>\n                    Preventive medicine has historically favored reducing a risk factor by a small amount in the entire population rather than by a large amount in high\u2010risk individuals. The use of multivariable risk prediction tools, however, may affect the relative merits of this strategy.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    This study uses risk factor data from the National Health and Nutrition Examination Survey III to simulate a population of more than 100 million Americans aged thirty or older with no history of CV disease. Three strategies that could affect CV events, CV mortality, and quality\u2010adjusted life years were examined: (1) a population\u2010based strategy that treats all individuals with a low\u2010 or moderate\u2010intensity intervention (in which the low\u2010intensity intervention represents a public health campaign with no demonstrable adverse effects), (2) a targeted strategy that treats individuals in the top 25 percent based on a single risk factor (LDL), and (3) a risk\u2010targeted strategy that treats individuals in the top 25 percent based on overall CV risk (as predicted by a multivariable prediction tool). The efficiency of each strategy was compared while varying the intervention's intensity and associated adverse effects, and the accuracy of the risk prediction tool.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Findings:<\/jats:bold>\n                    The LDL\u2010targeted strategy and the low\u2010intensity population\u2010based strategy were comparable for CV events prevented over five years (0.79 million and 0.75 million, respectively), as were the risk\u2010targeted strategy and moderate\u2010intensity population\u2010based strategy (1.56 million and 1.87 million, respectively). The risk\u2010targeted strategy, however, was more efficient than the moderate\u2010intensity population\u2010based strategy (number needed to treat [NNT] 19 vs. 62). Incorporating a small degree of treatment\u2010related adverse effects greatly magnified the relative advantages of the risk\u2010targeted approach over other strategies. Reducing the accuracy of the prediction tool only modestly decreased this greater efficiency.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    A population\u2010based prevention strategy can be an excellent option if an intervention has almost no adverse effects. But if the intervention has even a small degree of disutility, a targeted approach using multivariable risk prediction can prevent more morbidity and mortality while treating many fewer people.\n                  <\/jats:p>","DOI":"10.1111\/j.1468-0009.2008.00534.x","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T10:49:00Z","timestamp":1227696540000},"page":"557-580","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["The Relative Merits of Population\u2010Based and Targeted Prevention Strategies"],"prefix":"10.1111","volume":"86","author":[{"given":"DONNA M.","family":"ZULMAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SANDEEP","family":"VIJAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GILBERT S.","family":"OMENN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RODNEY A.","family":"HAYWARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,11,21]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(91)90861-B"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.6.445"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(01)01209-2"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2003.11.012"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2003.09.002"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyh405"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00164.x"},{"issue":"23","key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/jama.1995.03530230025025","article-title":"Cost\u2010Effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients with Nonvalvular Atrial Fibrillation","volume":"274","author":"Gage B.F.","year":"1995","journal-title":"Journal of the American Medical Association"},{"issue":"9","key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jama.1991.03460090093039","article-title":"Cost\u2010Effectiveness of HMG\u2010CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart Disease","volume":"265","author":"Goldman L.","year":"1991","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.104.4.491"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.24.6.1571"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-6-18"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(03)00081-2"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009590"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.18.1977"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.10.1209"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01160-9"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1047-2797(97)00107-5"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/121.5.697"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-4-248"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0887-378X.2004.00327.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.24.2340"},{"key":"e_1_2_6_25_1","first-page":"2213","article-title":"Nonlinear Discriminant Analysis and Prognostic Factor Classification in Node\u2010Negative Primary Breast Cancer Using Probabilistic Neural Networks","volume":"20","author":"Le Goff J.M.","year":"2000","journal-title":"Anticancer Research"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960170305"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.21.2591"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90878-9"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7542.659"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.104.3.263"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1161\/circ.106.25.3143"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-004-0614-4"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7267.983"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7304.75"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(97)00117-1"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1249\/01.MSS.0000145443.02568.7A"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0010027"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/14.1.32"},{"key":"e_1_2_6_39_1","volume-title":"The Strategy of Preventive Medicine","author":"Rose G.","year":"1992"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)11415-0"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-7-199710010-00006"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-200014020-00004"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.14.5.570"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)00203-4"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(91)90151-X"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7425.1196"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2000.tb03126.x"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199111000-00007"},{"key":"e_1_2_6_49_1","volume-title":"Population Pyramids for the United States","author":"U.S. Census Bureau, Population Division\/International Programs Center","year":"2004"},{"issue":"7404","key":"e_1_2_6_50_1","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/bmj.326.7404.1419","article-title":"A Strategy to Reduce Cardiovascular Disease by More than 80%","volume":"326","author":"Wald N.J.","year":"2003","journal-title":"British Medical Journal"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90863-X"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.10.1068"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199808000-00012"}],"container-title":["The Milbank Quarterly"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-0009.2008.00534.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-0009.2008.00534.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T04:06:44Z","timestamp":1696910804000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-0009.2008.00534.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,21]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1111\/j.1468-0009.2008.00534.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-0009.2008.00534.x","archive":["Portico"],"relation":{},"ISSN":["0887-378X","1468-0009"],"issn-type":[{"value":"0887-378X","type":"print"},{"value":"1468-0009","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,21]]},"assertion":[{"value":"2008-11-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}